Progenics Falls Most in 18 Months After Deaths in Drug Trial

... Progenics tumbled 27 percent to $4.50 at the close in New York, the biggest intraday drop since July 30, 2012. The Tarrytown, New York-based company's stock has gained 52 percent in the past 12 months. The targeted chemotherapy treatment for ...

http://ift.tt/1k9yhpJ